GeoVax Labs Statistics

Total Valuation

GeoVax Labs has a market cap or net worth of $14.39 million. The enterprise value is $14.73 million.

Market Cap	14.39M
Enterprise Value	14.73M

Important Dates

The last earnings date was Thursday, May 1, 2025, after market close.

Earnings Date	May 1, 2025
Ex-Dividend Date	n/a

Share Statistics

GeoVax Labs has 13.84 million shares outstanding. The number of shares has increased by 284.96% in one year.

Current Share Class	13.84M
Shares Outstanding	13.84M
Shares Change (YoY)	+284.96%
Shares Change (QoQ)	+23.95%
Owned by Insiders (%)	0.56%
Owned by Institutions (%)	3.66%
Float	13.76M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.45
Forward PS	2.19
PB Ratio	1,866.17
P/TBV Ratio	1,866.17
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2.63
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,153.98

Financial Efficiency

Return on equity (ROE) is -78,814.57% and return on invested capital (ROIC) is -49,592.82%.

Return on Equity (ROE)	-78,814.57%
Return on Assets (ROA)	-915.19%
Return on Invested Capital (ROIC)	-49,592.82%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	$328,916
Profits Per Employee	-$1.44M
Employee Count	17
Asset Turnover	3.32
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -40.34% in the last 52 weeks. The beta is 3.49, so GeoVax Labs's price volatility has been higher than the market average.

Beta (5Y)	3.49
52-Week Price Change	-40.34%
50-Day Moving Average	1.03
200-Day Moving Average	2.17
Relative Strength Index (RSI)	53.36
Average Volume (20 Days)	246,990

Short Selling Information

The latest short interest is 776,738, so 5.61% of the outstanding shares have been sold short.

Short Interest	776,738
Short Previous Month	895,132
Short % of Shares Out	5.61%
Short % of Float	5.64%
Short Ratio (days to cover)	1.69

Income Statement

In the last 12 months, GeoVax Labs had revenue of $5.59 million and -$24.50 million in losses. Loss per share was -$3.23.

Revenue	5.59M
Gross Profit	-18.12M
Operating Income	-24.67M
Pretax Income	-26.92M
Net Income	-24.50M
EBITDA	-24.57M
EBIT	-24.67M
Loss Per Share	-$3.23

Full Income Statement

Balance Sheet

The company has $7,439 in cash and n/a in debt, giving a net cash position of $7,439 or $0.00 per share.

Cash & Cash Equivalents	7,439
Total Debt	n/a
Net Cash	7,439
Net Cash Per Share	$0.00
Equity (Book Value)	7,898
Book Value Per Share	0.00
Working Capital	10,612

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-441.13%
Pretax Margin	-438.16%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GeoVax Labs does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-284.96%
Shareholder Yield	-284.96%
Earnings Yield	-166.23%
FCF Yield	n/a

Analyst Forecast

The average price target for GeoVax Labs is $12.40, which is 1,092.31% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$12.40
Price Target Difference	1,092.31%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 31, 2024. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	Jan 31, 2024
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a